PMID- 23175187 OWN - NLM STAT- MEDLINE DCOM- 20130815 LR - 20211021 IS - 1476-5403 (Electronic) IS - 1350-9047 (Print) IS - 1350-9047 (Linking) VI - 20 IP - 3 DP - 2013 Mar TI - TLR2-dependent selective autophagy regulates NF-kappaB lysosomal degradation in hepatoma-derived M2 macrophage differentiation. PG - 515-23 LID - 10.1038/cdd.2012.146 [doi] AB - Autophagy is a lysosomal pathway for cellular homeostasis control. Both non-selective bulk autophagy and selective autophagy of specific proteins or organelles have been found. Selective autophagy prevents cells from pathogen invasion and stress damage, but its role in regulating transcriptional factors is not clear. Using a macrophage cell differentiation model, the role of autophagy in nuclear factor-kappaB (NF-kappaB) regulation is investigated. The bone marrow-derived macrophages (BMDMs) will differentiate into a M2-like phenotype in the presence of hepatoma tumor cell condition medium (CM). The TLR2 signaling drives this M2 polarization and causes NF-kappaB p65 degradation via lysosome-dependent pathway. The CM-induced ubiquitinated- NF-kappaB p65 forms aggresome-like structures (ALS) in the cytoplasm of cultured and hepatoma-associated M2 macrophages. This NF-kappaB p65-contained ALS is recognized by p62/SQSTM1 and degraded by selective autophagy. Treatment with the lysosomal inhibitor bafilomycin A1 or the knockdown of Atg5 can prevent CM-induced NK-kappaB p65 degradation and induce M2 macrophages to produce a high level of pro-inflammatory cytokines. Furthermore, TLR2 signal induces sustained phosphorylation of extracellular signal-regulated kinase 1/2 to facilitate this autophagy-dependent NF-kappaB regulation. Our finding provides a novel pathway of NF-kappaB regulation by p62/SQSTM1-mediated selective autophagy. FAU - Chang, C-P AU - Chang CP AD - Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China. cpchang@mail.ncku.edu.tw FAU - Su, Y-C AU - Su YC FAU - Hu, C-W AU - Hu CW FAU - Lei, H-Y AU - Lei HY LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121123 PL - England TA - Cell Death Differ JT - Cell death and differentiation JID - 9437445 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Atg5 protein, mouse) RN - 0 (Autophagy-Related Protein 5) RN - 0 (Culture Media, Conditioned) RN - 0 (Cytokines) RN - 0 (Macrolides) RN - 0 (Microtubule-Associated Proteins) RN - 0 (RNA, Small Interfering) RN - 0 (SQSTM1 protein, human) RN - 0 (Sequestosome-1 Protein) RN - 0 (Toll-Like Receptor 2) RN - 0 (Transcription Factor RelA) RN - 88899-55-2 (bafilomycin A1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3) SB - IM MH - Adaptor Proteins, Signal Transducing/antagonists & inhibitors/genetics/metabolism MH - Animals MH - *Autophagy MH - Autophagy-Related Protein 5 MH - Bone Marrow Cells/cytology MH - Carcinoma, Hepatocellular/metabolism MH - Cell Differentiation MH - Cell Line, Tumor MH - Culture Media, Conditioned/pharmacology MH - Cytokines/metabolism MH - Female MH - Lysosomes/drug effects/*metabolism MH - Macrolides/pharmacology MH - Macrophages/*cytology/drug effects/metabolism MH - Mice MH - Mice, Inbred BALB C MH - Mice, Knockout MH - Microtubule-Associated Proteins/antagonists & inhibitors/genetics/metabolism MH - Mitogen-Activated Protein Kinase 1/metabolism MH - Mitogen-Activated Protein Kinase 3/metabolism MH - Phosphorylation MH - RNA Interference MH - RNA, Small Interfering/metabolism MH - Sequestosome-1 Protein MH - Toll-Like Receptor 2/*metabolism MH - Transcription Factor RelA/*metabolism PMC - PMC3569990 EDAT- 2012/11/24 06:00 MHDA- 2013/08/16 06:00 PMCR- 2014/03/01 CRDT- 2012/11/24 06:00 PHST- 2012/11/24 06:00 [entrez] PHST- 2012/11/24 06:00 [pubmed] PHST- 2013/08/16 06:00 [medline] PHST- 2014/03/01 00:00 [pmc-release] AID - cdd2012146 [pii] AID - 10.1038/cdd.2012.146 [doi] PST - ppublish SO - Cell Death Differ. 2013 Mar;20(3):515-23. doi: 10.1038/cdd.2012.146. Epub 2012 Nov 23.